In vitro markers for virulence in Yersinia ruckeri.
In this study, different traits that have been associated with bacterial virulence were studied in Yersinia ruckeri. Two isolates that had been shown to cause disease and mortality in experimentally infected rainbow trout were compared with five avirulent isolates. Both virulent isolates showed high adhesion to gill and intestinal mucus of rainbow trout, whereas the majority of non-virulent strains demonstrated significantly lower adhesion. A decrease in adherence capability following bacterial treatment with sodium metaperiodate and proteolytic enzymes suggested the involvement of carbohydrates and proteins. All strains were able to adhere to and invade chinook salmon embryo cell line (CHSE-214), fathead minnow epithelial cell line (FHM) and rainbow trout liver cell line (R1). One non-virulent strain was highly adhesive and invasive in the three cell lines, whereas the virulent strains showed moderate adhesive and invasive capacity. The internalization of several isolates was inhibited by colchicine and cytochalasin-D, suggesting that microtubules and microfilaments play a role. For all strains, intracellular survival assays showed a decrease of viable bacteria in the cells 6 h after inoculation, suggesting that Y. ruckeri is not able to multiply or survive inside cultured cells. Analysis of the susceptibility to the bactericidal effect of rainbow trout serum demonstrated that virulent Y. ruckeri strains were serum resistant, whereas non-virulent strains were generally serum sensitive.
Tobback
E
E
Department of Pathology, Bacteriology and Avian Diseases, Ghent University, Merelbeke, Belgium. eltobbac.Tobback@UGent.be
Decostere
A
A
Hermans
K
K
Van den Broeck
W
W
Haesebrouck
F
F
Chiers
K
K
D000818:Animals; D001422:Bacterial Adhesion / Q000187:drug effects; D015415:Biomarkers; D002241:Carbohydrates / Q000494:pharmacology; D002460:Cell Line; D003078:Colchicine / Q000494:pharmacology; D015638:Cytochalasin D / Q000494:pharmacology; D004798:Enzymes / Q000494:pharmacology; D005393:Fish Diseases / Q000382:microbiology*; D005399:Fishes; D005880:Gills / Q000382:microbiology; D042541:Intracellular Space / Q000382:microbiology; D008855:Microscopy, Electron, Scanning; D008934:Mitogens / Q000494:pharmacology; D009093:Mucus / Q000382:microbiology*; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D017686:Oncorhynchus mykiss; D010504:Periodic Acid / Q000494:pharmacology; D050257:Tubulin Modulators / Q000494:pharmacology; D015009:Yersinia Infections / Q000382:microbiology / Q000662:veterinary*; D044124:Yersinia ruckeri / Q000472:pathogenicity*
D015415:Biomarkers; D002241:Carbohydrates; D004798:Enzymes; D008934:Mitogens; D019384:Nucleic Acid Synthesis Inhibitors; D050257:Tubulin Modulators; D010504:Periodic Acid; D015638:Cytochalasin D; C009288:metaperiodate; D003078:Colchicine